Skip to main navigation Skip to search Skip to main content

Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria

  • M. Balwani
  • , E. Sardh
  • , P. Ventura
  • , P. A. Peiró
  • , D. C. Rees
  • , U. Stölzel
  • , D. M. Bissell
  • , H. L. Bonkovsky
  • , J. Windyga
  • , K. E. Anderson
  • , C. Parker
  • , S. M. Silver
  • , S. B. Keel
  • , J. D. Wang
  • , P. E. Stein
  • , P. Harper
  • , D. Vassiliou
  • , B. Wang
  • , J. Phillips
  • , A. Ivanova
    • J. G. Langendonk, R. Kauppinen, E. Minder, Y. Horie, C. Penz, J. Chen, S. Liu, J. J. Ko, M. T. Sweetser, P. Garg, A. Vaishnaw, J. B. Kim, A. R. Simon, L. Gouya

Research output: Contribution to journal › Article › peer-review

489   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science